Abbreviations
| Abbreviation | Full Form | Meaning | Usage Example | Context |
|---|---|---|---|---|
FISH | Fluorescence In Situ Hybridization | A molecular cytogenetic technique that uses fluorescent probes to detect selected nucleic acid sequences within cells or tissue sections. | FISH was used to assess a chromosomal abnormality in a tissue sample. | Molecular cytogenetics |
PCR | Polymerase Chain Reaction | A molecular technique that amplifies selected DNA sequences and is widely used in disease-associated genetic testing. | PCR was used to detect a specific DNA sequence in a diagnostic sample. | Molecular testing |
NGS | Next-Generation Sequencing | A group of high-throughput sequencing technologies used to analyze genetic alterations in disease-related samples. | NGS was used to identify genetic variants in a tumor specimen. | Genomic analysis |
IHC | Immunohistochemistry | A tissue-based method for identifying proteins using specific antibodies and detection systems. | IHC was used to evaluate the expression of a selected biomarker. | Protein biomarker detection |
ISH | In Situ Hybridization | A method for detecting DNA or RNA sequences directly within preserved cells or tissue. | ISH was used to identify viral RNA within a tissue section. | Spatial molecular detection |
CNV | Copy Number Variation | A genomic alteration involving the gain or loss of copies of a DNA segment. | CNV analysis identified a genomic amplification in the sample. | Genomic alteration |
MSI | Microsatellite Instability | A condition involving variation in the lengths of microsatellite sequences caused by errors in DNA mismatch repair. | MSI testing was used to characterize a tumor's molecular features. | Genomic instability |
MMR | Mismatch Repair | A DNA repair pathway that corrects mismatched bases and small insertion-deletion loops generated during DNA replication. | MMR status was assessed during molecular pathology evaluation. | DNA repair |
TMB | Tumor Mutational Burden | A measurement of the number of somatic mutations within a defined amount of tumor DNA. | TMB was reported as part of the tumor's molecular profile. | Tumor genomics |
ctDNA | Circulating Tumor DNA | DNA fragments released from tumor cells into body fluids, particularly blood, that can be analyzed as a molecular biomarker. | ctDNA analysis can provide information about tumor-associated genetic alterations. | Liquid biopsy |